Mesothelioma Clinical Trial: MESODEC
Key takeaways: MESODEC is an ongoing mesothelioma clinical clinical trial (currently in Phase II) that is vaccine and chemotherapy-based. By introducing dendritic cells–immune cells that display antigens tobe attacked–to coordinate an immune response against a protein expressed by mesotheliomacells, researchers are hoping to incite an immune response against mesothelioma. Additionally,the chemotherapeutic aspect of the trial […]
